First Long Island Investors’s AstraZeneca AZN Stock Holding History

First Long Island Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$379K	Sell	1,920 -1	-0.1%	-$193	0.03%	54
2025 Q4	$353K	Hold	1,921	–	–	0.03%	58
2025 Q3	$295K	Hold	1,921	–	–	0.02%	57
2025 Q2	$268K	Hold	1,921	–	–	0.02%	57
2025 Q1	$282K	Hold	1,921	–	–	0.02%	60
2024 Q4	$252K	Hold	1,921	–	–	0.02%	63
2024 Q3	$299K	Hold	1,921	–	–	0.02%	62
2024 Q2	$300K	Buy	+1,921	New	+$289K	0.03%	58

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

First Long Island Investors's AZN Position: Q1 2026 in Review

First Long Island Investors reduced its AstraZeneca (AZN) stake by 0.05% in Q1 2026, selling an estimated $193 and leaving 1,920 shares worth $379K. The position accounts for 0.03% of the portfolio, ranked #54.

First Long Island Investors first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

First Long Island Investors held 1,920 shares of AstraZeneca worth $379K as of Q1 2026.
First Long Island Investors sold 1 AstraZeneca share in Q1 2026, an estimated $193.
AstraZeneca made up 0.03% of First Long Island Investors's portfolio in Q1 2026, its #54 holding.
First Long Island Investors first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on First Long Island Investors's 13F filing for Q1 2026, filed 15 May 2026.